Dartmouth-Hitchcock Medical Center — Lebanon, New Hampshire

Public research footprint of Dartmouth-Hitchcock Medical Center, compiled from the ClinicalTrials.gov public registry.

1,604

Registered studies

442

Active

198

Recruiting now

918

Completed

194

Stopped or withdrawn

Most-studied conditions

Metastatic Non-Cutaneous Melanoma · Recurrent Melanoma · Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative

Recently updated registry entries

NCT03775265 — Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle… (Active Not Recruiting)
NCT05675410 — A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… (Recruiting)
NCT06589804 — Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Dartmouth-Hitchcock Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.